Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Basal Cell × 1-phenyl-3,3-dimethyltriazene × Clear all

Phase

Phase 1 4 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 1 Neoplasms 1 Keratosis, Actinic 1 Carcinoma, Basal Cell 1

Interventions

Imiquimod 4 methyl 5-aminolevulinate 3 Photochemotherapy 2 Tretinoin 1 Surgical Procedures, Operative 1 Niacinamide 1 Fluorouracil 1 Electroporation 1 Calcium Chloride 1 BF-200 ALA 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00472043 2024-08-06

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Galderma R&D

Phase 3 Completed

66 enrolled 15 charts

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡